Correlation of acetylator phenotype with peripheral, autonomic and central neuropathy in Northern Indian non-insulin-dependent diabetes mellitus patients A. MisraV. MittalJ. S. Bajaj CLINICAL TRIALS Pages: 419 - 424
Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model G. B. CurtisG. H. JohnsonP. G. Lacouture PHARMACODYNAMICS Pages: 425 - 429
Comparative trough effects of formoterol and salmeterol on lymphocyte β2-adrenoceptor – regulation and bronchodilatation I. AzizL. C. McFarlaneB. J. Lipworth PHARMACODYNAMICS Pages: 431 - 436
Plasma protein binding of tamsulosin hydrochloride in renal disease: role of α1-acid glycoprotein and possibility of binding interactions H. MatsushimaH. KamimuraM. Miyazaki PHARMACOKINETICS AND DISPOSITION Pages: 437 - 443
The effect of the menstrual cycle on the pharmacokinetics of caffeine in normal, healthy eumenorrheic females G. H. KamimoriA. JoubertN. D. Eddington PHARMACOKINETICS AND DISPOSITION Pages: 445 - 449
Effect of fluvoxamine on the pharmacokinetics of quinidine P. DamkierL. L. HansenK. Brøsen PHARMACOKINETICS AND DISPOSITION Pages: 451 - 456
Dextromethorphan O-demethylation polymorphism in an African-American population N. HeH. I. DanielD. Shockley PHARMACOKINETICS AND DISPOSITION Pages: 457 - 459
Pharmacokinetics of oral entacapone after frequent multiple dosing and effects on levodopa disposition J. RouruA. GordinM. Scheinin PHARMACOKINETICS AND DISPOSITION Pages: 461 - 467
Absence of an interaction between artesunate and atovaquone – proguanil M. van VugtM. D. EdsteinF. Nosten PHARMACOKINETICS AND DISPOSITION Pages: 469 - 474
The effect of short-term dipyrone administration on cyclosporin pharmacokinetics Y. CaracoE. Zylber-KatzM. Levy PHARMACOKINETICS AND DISPOSITION Pages: 475 - 478
Markers to analyse the prescribing of non-steroidal anti-inflammatory drugs in ambulatory care A guide to pursuing rational and safe prescribing I. SchubertP. IhleL. von Ferber PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 479 - 486
Are antipsychotic drugs potentially chemopreventive agents for cancer? J. A. CarrilloJ. Benítez LETTER TO THE EDITORS Pages: 487 - 488